Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Antiviral Therapy|December 7, 2016
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trialMelanie Thompson, Jacob P Lalezari, Richard Kaplan, et al.
Pharmacology Research & Perspectives|November 17, 2020
Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitorSamit R Joshi, Disala Fernando, Stephanie Igwe, et al.
British Journal of Clinical Pharmacology|August 24, 2021
Lack of pharmacokinetic interaction between the HIV-1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy womenTeodora Pene Dumitrescu, Thomas J Greene, Samit R Joshi, et al.
The Lancet. HIV|January 15, 2016
Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trialSamir K Gupta, Grace A McComsey, John Lombaard, et al.
Plos One|October 24, 2018
Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trialJavier Morales-Ramirez, Johannes R Bogner, Jean-Michel Molina, et al.
Aging Cell|August 23, 2022
Metabolomic and transcriptomic signatures of influenza vaccine response in healthy young and older adultsChih-Hung Chou, Subhasis Mohanty, Heather A Kang, et al.
Eclinicalmedicine|December 8, 2025
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b studySamit R Joshi, Ezequiel Cordova, Essack Mitha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2022
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254Christoph D Spinner, Franco Felizarta, Giuliano Rizzardini, et al.
The Journal of Infectious Diseases|November 5, 2014
Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adultsSubhasis Mohanty, Samit R Joshi, Ikuyo Ueda, et al.
The Lancet. HIV|October 2, 2015
Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trialJacob P Lalezari, Gulam H Latiff, Cynthia Brinson, et al.
Pageof 3